Stryker Corporation $SYK Stock Holdings Decreased by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. lowered its stake in Stryker Corporation (NYSE:SYK) by 81.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 10,690 shares of the medical technology company’s stock after selling 46,461 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Stryker were worth $3,757,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of SYK. United Financial Planning Group LLC bought a new stake in shares of Stryker in the 3rd quarter worth about $27,000. CGC Financial Services LLC bought a new stake in shares of Stryker in the 4th quarter worth about $29,000. Strive Asset Management LLC bought a new stake in shares of Stryker during the 3rd quarter valued at about $30,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Stryker during the 3rd quarter valued at about $34,000. Finally, Copia Wealth Management grew its position in shares of Stryker by 181.6% during the 3rd quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock valued at $40,000 after buying an additional 69 shares during the last quarter. Institutional investors own 77.09% of the company’s stock.

Stryker Trading Down 0.0%

Stryker stock opened at $316.39 on Monday. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The firm has a 50-day moving average price of $325.22 and a two-hundred day moving average price of $349.76. The firm has a market capitalization of $121.29 billion, a price-to-earnings ratio of 36.62, a PEG ratio of 1.99 and a beta of 0.80. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $404.87.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Sell-side analysts expect that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s payout ratio is presently 40.74%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on SYK shares. TD Cowen downgraded shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price objective for the company. in a research report on Monday, January 26th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Stryker in a research report on Friday, May 1st. Piper Sandler reaffirmed an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Evercore set a $355.00 price objective on shares of Stryker in a research report on Friday, May 1st. Finally, Wall Street Zen downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Sixteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Stryker currently has an average rating of “Moderate Buy” and a consensus target price of $395.48.

Insider Transactions at Stryker

In other Stryker news, VP M Kathryn Fink sold 5,220 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the completion of the transaction, the vice president directly owned 13,137 shares of the company’s stock, valued at $3,728,937.45. The trade was a 28.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 4.60% of the stock is owned by insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.